Dysregulation of human trophoblast invasion and differentiation with placental hypoxia can result in preeclampsia, a hypertensive disorder of pregnancy. Herein, we characterized the role and regulation of miR-1246, which is markedly induced during human syncytiotrophoblast differentiation. miR-1246 targets GSK3b and AXIN2, inhibitors of WNT/b-catenin signaling, which is crucial for placental development, and is predicted to target JARID2, which promotes silencing of developmentally regulated genes. Human cytotrophoblasts cultured in 20% O 2 spontaneously differentiate to syncytiotrophoblast with induction of hCYP191A/aromatase, a marker of differentiation. miR-1246 was induced .150-fold during syncytiotrophoblast differentiation in 20% O 2 , whereas targets-GSK3b, AXIN2, and JARID2-were significantly decreased. However, when cytotrophoblasts were cultured in 2% O 2 , miR-1246 and aromatase induction were prevented. miR-1246 was significantly decreased in placentas of women with severe preeclampsia, whereas AXIN2, GSK3b, and JARID2 were increased, compared with normotensive subjects. To identify factors that regulate miR-1246, we investigated the redox-regulated transcription factor NRF2, which has predicted binding sites in the miR-1246 promoter. Intriguingly, NRF2 messenger RNA was upregulated during syncytiotrophoblast differentiation and significantly reduced by hypoxia and in preeclamptic placentas. Moreover, NRF2 knockdown in cytotrophoblasts inhibited induction of miR-1246 and hCYP19A1, as well as transcription factors C/EBPb and PPARg, which are implicated in placental differentiation. Using chromatin immunoprecipitation-quantitative polymerase chain reaction, we found that binding of endogenous NRF2 to the miR-1246 and hCYP191A promoters increased during syncytiotrophoblast differentiation. Thus, NRF2 promotes syncytiotrophoblast differentiation by inducing C/EBPb, PPARg, hCYP19A1, and miR-1246, which targets WNT inhibitors and JARID2 and is dysregulated in preeclampsia. (Endocrinology 159: 2022(Endocrinology 159: -2033(Endocrinology 159: , 2018 E arly during the first trimester of pregnancy when placental O 2 tension is low, cytotrophoblasts (CytTs) proliferate and invade the maternal uterus and spiral arteries replacing their endothelial lining and intercalating into the vascular smooth muscle layer to convert them to low-resistance/high-capacitance vessels (1). This results in a large increase in placental perfusion with increased O 2 tension (2), which serves a permissive role in differentiation of the placental syncytiotrophoblast (SynT), an invasive, multinucleated cell layer formed by fusion and differentiation of underlying mitotically active mononuclear CytTs. This differentiation process is essential for placental implantation, growth, and pregnancy maintenance. Defective CytT invasion of the uterine wall and spiral artery remodeling are implicated in preeclampsia (PE) (3), a hypertensive disorder that occurs in 5% to 8% Abbreviations: ChIP, chromatin immunoprecipitation; CytT, cytotrophoblast; FZD5, frizzled 5; GCM1, glial cells missing 1; IgG, immunoglobulin G; JARID2, jumonji, AT-rich interactive domain 2; miRNA, microRNA; MPE, mild preeclampsia; mRNA, messenger RNA; NRF2, nuclear factor erythroid 2-related factor 2; PE, preeclampsia; PRC2, polycomb repressor complex 2; qPCR, quantitative polymerase chain reaction; SEM, standard error of the mean; SPE, severe preeclampsia; SynT, syncytiotrophoblast; RT, reverse transcription; RT-qPCR, reverse transcription quantitative polymerase chain reaction.
of pregnancies worldwide, increases morbidity and mortality rates among mothers and infants, and contributes to ;40% of premature births (4, 5) . In PE, the placenta is relatively hypoxic; thus, O 2 availability to the hormoneproducing SynT is reduced (6) . Although the etiology of PE is unclear, the placenta is prerequisite for the disease, because the symptoms resolve after delivery of the placenta (7) .
The SynT layer mediates the exchange of gases, nutrients, and other factors between the maternal and fetal circulations, protects the hemiallogeneic fetus against attack by the maternal immune system (8, 9) , and is responsible for the production of growth factors, protein, and steroid hormones, including estrogens and progesterone. Placental estrogen synthesis from C 19 steroids is catalyzed by aromatase P450 (encoded by the hCYP19A1 gene). Trophoblast stem cells and CytTs do not express hCYP19A1/aromatase; however, when CytTs fuse to form multinucleated SynT in culture, placenta-specific messenger RNA (mRNA) transcripts (hCYP19I.1) of the hCYP19A1 gene are markedly induced (10, 11) . We observed that SynT differentiation and aromatase induction are dependent on a critical O 2 tension. When midgestation human trophoblasts were cultured in a hypoxic (2% O 2 ) environment, SynT differentiation and induction of hCYP19A1 mRNA were prevented (12) . Estrogens formed by placental aromatase may enhance angiogenesis, uteroplacental blood flow, and reduce systemic vascular resistance (13) (14) (15) (16) . Previously, we observed that the placenta-specific promoter (promoter I.1) of the hCYP19A1 gene contains response elements for estrogen receptor-a, estrogen-related receptor-g, Sp1, and glial cells missing 1 (GCM1), a transcription factor that serves a fundamental role in trophoblast development and SynT differentiation (17) (18) (19) . These transcription factors comprise an enhanceosome that is crucial for induction of hCYP191A expression.
To further define mechanisms that underlie human trophoblast differentiation, we have investigated the roles of microRNAs (miRNAs). We previously performed miRNA microarray analysis of total RNA from freshly isolated human CytTs (0 hours) and from SynT after 24 and 48 hours of culture in 20% O 2 . Among the differentially expressed miRNAs, the miR-17;92 cluster and its paralogs (20) and primate-specific/placenta-specific miR-515 family members (21) were found to be significantly downregulated upon SynT differentiation. Interestingly, these miRNAs were significantly upregulated in placentas from women with PE (20, 21) . The miR-515 family belongs to the placenta-specific chromosome 19 miRNA cluster, one of the largest miRNA gene clusters in humans (22) . Our recent studies have further revealed important targets of these miRNAs, including hCYP19A1, GCM1, and the WNT receptor frizzled 5 (FZD5) (20, 21) , which serve critical roles in human trophoblast differentiation. Downregulation of miR-515 allows upregulation of GCM1 and FZD5, which exist in a positive feedforward loop (21) . Studies in gene-targeted mice indicate that Fzd5/b-catenin maintains elevated expression of Gcm1, which promotes trophoblast fusion, in part, via its action to enhance expression of Syncytin 1 (23) . GCM1 also regulates expression of placental growth factor (24) , as well as hCYP19A1/ aromatase (20, 21, 25) . Moreover, it was observed that the b-catenin/GCM1/syncytin pathway mediated trophoblast fusion in vitro in BeWo cells (26) .
In the present study, we have investigated the regulation and functional roles of miR-1246, which was found to be significantly upregulated during trophoblast differentiation in the miRNA microarray. miR-1246 was proven to target AXIN2 and GSK3b, inhibitors of Wnt/b-catenin signaling pathway (27) . Additionally, miR-1246 is predicted to target Jumonji, AT-rich interactive domain 2 (JARID2), which recruits the polycomb repressor complex 2 (PRC2) to promoters of developmentally regulated genes (28) (29) (30) . In the course of these studies, we discovered that the marked induction of miR-1246 during SynT differentiation was mediated by the redox-sensitive transcription factor nuclear factor erythroid 2-related factor 2 (NRF2). Moreover, NRF2 may serve an important role in O 2 -regulated SynT differentiation through its action to induce hCYP19A1 expression and possibly promote stem/progenitor cell differentiation through suppression of JARID2 (31) . Notably, nuclear localization of NRF2 was found to be decreased in placentas from PE subjects, compared with normotensive controls (32) .
Materials and Methods

Acquisition of human placental tissues and primary culture of human trophoblast cells
This study was approved by the Institutional Review Board of the University of Texas Southwestern Medical Center. Informed consent was obtained from all participants. Classification of PE vs normotensive subjects was in accord with recently revised American College of Obstetricians and Gynecologists guidelines (33) . There are .14,000 deliveries per year at Parkland Hospital; of these, ;700 have true PE and .200 would be expected to undergo cesarean section, of which the distribution for mild PE (MPE) and severe PE (SPE) is 40% and 60% of the total cases, respectively. Clinical characteristics of the study patients are given in Table 1 . The placental tissues were immediately placed in RNAlater (Qiagen, Foster City, CA) solution and snap frozen at 280°C.
CytTs were isolated from midgestation human placenta (Advanced Bioscience Resources, Alameda, CA) or from term placenta (Parkland Hospital) and placed in primary culture, as described in detail previously (11) . We have observed that CytTs isolated from midgestation and term placental tissues manifest similar temporal and fold induction of aromatase and miR-1246 expression (data not shown). Briefly, the placental tissues were washed with Hanks balanced salt solution (pH 7.4) (Life Technologies, Grand Island, NY) and then finely minced and digested with 2.5% trypsin in Hanks balanced salt solution at 37°C for 20 minutes. At the end of the digestion, the supernatant was collected, layered over 10 mL of serum, and then briefly centrifuged at 1000 3 g. The resulting pellet was suspended in Dulbecco's modified Eagle medium (Life Technologies), filtered, and layered over a Percoll gradient (70% to 5%). This procedure was repeated three times with the pellet from the original trypsin digestion. The gradients were centrifuged at 1800 3 g for 20 minutes at room temperature, and cells in the middle layer (density, 1.045 to 1.062 g/mL) were collected, washed, and counted. The cells were then resuspended in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum and 1.2% antibiotic/antimycotic solution (Life Technologies) and plated at a density of 2 
Reverse transcription quantitative polymerase chain reaction
Total RNA was isolated from trophoblast cells cultured for 0, 18, 36, or 72 hours using a miRNAeasy kit from Qiagen. To determine the expression of miR-1246, 5-10 ng of total RNA was reverse transcribed using a TaqMan miRNA reverse transcription (RT) kit (Applied Biosystems, Foster City, CA). TaqMan reactions were conducted using commercially available validated primer sets (Applied Biosystems) and normalized to U6 RNA as an internal control. Primer sets specific for the placenta-specific hCYP19A1 transcript, hCYP19I.1, along with constitutively expressed h36B4, were designed utilizing the Primer Express software program (PE Biosystems, Boston, MA): hCYP19I.1, forward primer, 5 0 -ACG GAA GGT CCT GTG CTC G-3 0 , reverse primer, 5 0 -GTA TCG GGT TCA GCA TTT CCA-3 0 ; h36B4, forward primer, 5 0 -TGC ATC AGT ACC CCA TTC TAT CA-3 0 , reverse primer, 5 0 -AAG GTG TAA TCC GTC TCC ACA GA-3 0 . Expression of GSK3b, AXIN2, and JARID2 were analyzed using QuantiTect primer sets (Qiagen). The relative abundance of each transcript was determined by reverse transcription quantitative polymerase chain reaction (RT-qPCR) using previously published methods (34) . All primer sets produced amplicons of the expected size and sequence. The relative fold changes were calculated using the comparative cycle times method with h36B4 as the internal reference.
Immunoblot analysis
Nuclear and cytoplasmic extracts were prepared from human trophoblast cells using a NE-PER extraction reagent kit (Pierce, Rockford, IL). Protein concentrations were determined by using the Bradford assay (35) kit (Bio-Rad, Hercules, CA) and resolved by electrophoresis on 4% to 12% Bis-Tris gels (Invitrogen). The expression of NRF2 was determined using rabbit polyclonal NRF2 antibody (catalog no. 12721, Cell Signaling Technology, Beverly, MA). Anti-histone H3 antibody (catalog no. 05-714) from Upstate Biotechnology (Lake Placid, NY) and anti-b-actin (catalog no. ab8227) from Abcam (Cambridge, MA) were used to quantify loading and transfer of nuclear and cytoplasmic protein, respectively. Horseradish peroxidase-conjugated anti-rabbit and anti-mouse immunoglobulin Gs (IgGs) from GE Health Care (Little Chalfont, Buckinghamshire, UK) were used as secondary antibodies. The membranes were incubated with enhanced SuperSignal West Pico chemiluminescent substrate (Thermo Fisher Scientific, Rockford, IL) and exposed to X-ray film.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were conducted using a ChIP kit (Millipore, Temecula, CA). Trophoblast cells were fixed with 1% formaldehyde on ice to cross-link proteins and DNA. After washing, the cells were homogenized and the chromatin was sheared by sonication to produce DNA fragments of ;500 to 1000 bp. Equivalent amounts of sheared DNA were used for immunoprecipitation with antibodies against NRF2 (Santa Cruz Biotechnology, Sun Valley, ID) or an equal amount of preimmune rabbit IgG (Millipore). The immunoprecipitates were then incubated with protein A/G agarose/salmon sperm DNA (Millipore), and the antibody/ protein/DNA/agarose complexes were collected. Crosslinking was subsequently reversed. The same amount of crosslinked sheared DNA without antibody precipitation was processed in the same manner and served as input control. DNA recovered after the reversal of crosslinking was used for quantitative polymerase chain reaction (qPCR) with the following primers: proximal hCYP19I.1 promoter, forward, 5
0 . qPCR was performed using SYBR Green Values are mean 6 standard deviation. In both normotensive and preeclamptic groups, one subject was African American; all remaining subjects were Hispanic. a P , 0.05 vs control.
PCR master mix (Applied Biosystems) on a Bio-Rad CFX384 real-time PCR detection system. Signals were normalized to input samples and expressed relative to that for control IgG. Samples from three independent ChIP experiments were analyzed.
Statistical analyses
Data are expressed as mean 6 standard error of the mean (SEM). Differences between groups were analyzed by one-way analysis of variance followed by a Tukey post hoc test using GraphPad Prism 7.03. Statistical significance was set as P values of ,0.05, and each experiment was performed at least three times (from three independent cell preparations).
Results
Expression of miR-1246 is increased and its proven and potential targets decreased during differentiation of human trophoblasts in primary culture
To identify miRNAs that are differentially expressed during human trophoblast differentiation, we previously conducted miRNA microarray analysis of RNA from freshly isolated CytTs before (0 hours) and after 24 and 48 hours of SynT differentiation in culture (20) . Among the 894 mature miRNA transcripts detected in the array with signal intensities .500 at each time point, 24 were significantly (P , 0.01, Student t test) downregulated and 16 were significantly upregulated at 24 and 48 hours compared with 0 hours (20) . Previously, we validated important targets and characterized expression of the miRNAs downregulated during trophoblast differentiation, including members of the miR-17;92 cluster and its paralogs (20) and the primate-specific and placentaspecific miR-515 family within the chromosome 19 cluster (21) . In the present study, we focused on miR-1246, which was dramatically upregulated in the microarray during SynT differentiation. Consistent with microarray data (20) , miR-1246 was markedly and significantly upregulated in the primary trophoblasts in association with the induction of aromatase (Fig. 1B) . Interestingly, miR-1246, which was found to be upregulated by 12.5-fold in the microarray, was upregulated by .150-fold when analyzed using RT-qPCR, further suggesting its potentially important role in trophoblast differentiation (Fig. 1C) .
To identify potential and confirmed targets of miRNA-1246, we used TargetScan and other other algorithms, such as miRNA.org and miRanda. Of great interest was the finding that miR-1246 has been proven to target AXIN2 and GSK3b, components of the cytoplasmic b-catenin "destruction complex" (35) . This complex inhibits Wnt-b-catenin signaling, which is known to be critical for labyrinth development and SynT fusion (26, 36, 37) . Notably, during SynT differentiation, expression of AXIN2 and GSK3b declined as miR-1246 levels increased ( Fig. 1D and 1E) . Moreover, miR-1246 also is Figure 1 . miR-1246 is upregulated and its potential targets downregulated in primary human trophoblasts during SynT differentiation in culture. (A) miRNAs found to be differentially regulated during human SynT differentiation using miRNA microarray (20) and potential targets of interest. (B-E) RNA from freshly isolated CytT (0 hours) and from SynT after 18, 36, and 72 hours of culture was analyzed by RT-qPCR for expression of (B) aromatase and (C) miR-1246, which were markedly upregulated, and the proven or predicted (28, 36) Values are the mean 6 SEM; n = 6 from three independent cell preparations. *P , 0.05 vs 0 hours. predicted to target JARID2, which recruits PRC2 to promoters of developmentally regulated genes, resulting in their transcriptional repression (29) . mRNA levels of JARID2 also were significantly reduced in SynT during differentiation compared with CytTs at 0 hours (Fig. 1F) .
miR-1246 is downregulated in placentas from subjects with SPE and in human trophoblasts cultured in hypoxia (2% O 2 )
The hallmark of PE is shallow trophoblast invasion and insufficient spiral artery remodeling, leading to persistent placental hypoxia and the release of various mediators into the maternal circulation, resulting in preeclamptic symptoms (3, 38) . Interestingly, expression levels of miR-1246 were significantly reduced in placental villous tissues from subjects with SPE, compared with placental tissues from women with MPE and normotensive gestation-matched controls ( Fig. 2A) . Expression of miR-1246 targets such as AXIN2, GSK3b, and JARID2 were significantly elevated in placentas of women with SPE compared with women with MPE and normotensive controls (Fig. 2B-2D) . Recently, it was observed that circulating levels of the inflammatory markers high-sensitivity C-reactive protein and procalcitonin were markedly elevated in women with SPE, compared with MPE (39) . Thus, the severity of PE is reflected by an enhanced proinflammatory state, which may influence expression of miR-1246 and its targets.
Because PE is associated with hypoxia, we analyzed the expression of miR-1246 in primary human trophoblast cells cultured in 2% vs 20% O 2 . We have used a 20% O 2 environment in this and all other experiments to simulate that of trophoblasts in direct contact with blood from the maternal spiral arteries, which is estimated to be 90 to 100 mm Hg (40) . Notably, we have observed that the temporal induction of aromatase and miR-1246 in cells cultured in a 10% vs 20% O 2 environment are comparable (data not shown). We found that similar to aromatase (Fig. 3A) , miR-1246 was significantly reduced after 36 hours of culture in 2% O 2 , compared with the cells cultured in 20% O 2 ( Fig. 3B) , whereas the known and predicted targets of miRNA-1246, such as AXIN2, GSK3b, and JARID2, failed to significantly decline and were expressed at levels similar to those in CytTs prior to culture (0 hours) (Fig. 3C, 3D , and 3E). Transcription factor NRF2 regulates expression of miR-1246 in human trophoblasts in culture through binding to the miR-1246 promoter
In light of the pronounced induction of miR-1246, during CytT to SynT differentiation, it was of interest to define the underlying transcriptional mechanisms. Using the TFBIND algorithm (http://tfbind.hgc.jp/), we searched 2 kb upstream of the transcriptional start site of the miR-1246 coding sequence for potential transcription factor binding sites. Among putative binding sites for several transcription factors, we were particularly interested in the redox-sensitive transcription factor NRF2 because of its suggested role in PE (32) . Interestingly, we observed that NRF2 was markedly induced during SynT differentiation, compared with the undifferentiated CytT (Fig. 4A) . As we observed for miR-1246 (Fig. 3B) , NRF2 expression was significantly decreased in the human trophoblasts after 36 hours of culture in 2% O 2 ( Fig. 4B ) and in placental villous tissues of women with SPE compared with MPE and normotensive controls (Fig. 4C) .
To further define the role of NRF2 in human SynT differentiation and in miR-1246 expression, freshly isolated human CytTs were transfected with small interfering RNA to NRF2 for 72 hours, or with a nontargeting control (Fig. 5A) . Interestingly, we found that NRF2 knockdown caused a pronounced reduction in expression of aromatase and miR-1246, whereas the putative miR-1246 target, JARID2, was upregulated (Fig. 5B,  5C , and 5D). Intriguingly, NRF2 knockdown inhibited expression of other transcription factors important for trophoblast differentiation, such as C/EBPb and PPARg ( Fig. 5E and 5F ). These findings suggest that NRF2 serves a regulatory role in the expression of aromatase and miR-1246 and regulates other transcription factors essential for trophoblast differentiation. To determine whether NRF2 directly binds to the hCYP191A placentaspecific promoter (promoter I.1) and to the promoter of miR-1246, we perfomed ChIP-qPCR. We observed a significant increase in binding of NRF2 to both the hCYP19I.1 and miR-1246 promoters at 20 hours of culture compared with undifferentiated CytTs at 0 hours ( Fig. 6A  and 6B ).
Discussion
During the past two decades it has become increasingly clear that miRNAs serve as potent regulators of genes involved in development, homeostasis, and cancer (41) . Moreover, it has been shown that miRNAs commonly act as "rheostats" rather than "on/off switches" in the regulation of gene expression (42) . During the last decade, our knowledge of the molecular mechanisms by which miRNAs regulate pregnancy and its associated disorders have begun to emerge (41, (43) (44) (45) . In studies of the roles of miRNAs in human trophoblast differentiation, we observed that the decline in c-Myc-regulated members of miR-17;92 cluster during CytT to SynT differentiation resulted in de-repression of its targets, GCM1 and hCYP19A1 (20) . More recently, we demonstrated that primate-specific/placenta-specific miR-515 family members within the chromosome 19 miRNA cluster also decline during SynT differentiation, resulting in upregulation of their targets, that is, GCM1, aromatase, and FZD5, a component of WNT/b-catenin signaling pathway (21) . Interestingly, both the miR-17;92 cluster and miR-515 family were significantly upregulated in placental villous tissues of women with PE compared with normotensive subjects, whereas their targets were downregulated (20, 21) . The WNT signaling pathway is a highly conserved signal transduction pathway and plays important roles in cell proliferation, differentiation, apoptosis, and cell migration. WNT signals transduce through at least three distinct pathways, commonly referred to as the canonical WNT/b-catenin, the WNT/Ca 2+ , and the planar cell polarity pathways (46) . The canonical WNT/b-catenin pathway has been extensively studied and has crucial functions in reproduction and in placental development (46) . GSK3b and AXIN2, as components of the b-catenin destruction complex, are negative regulators of canonical WNT signaling and tumor suppressor pathways (35) .
In the present study, we observed that miR-1246 was markedly induced during differentiation of human trophoblasts in primary culture in 20% O 2 ; miR-1246 expression was reduced in trophoblasts cultured in 2% O 2 and in placental villous tissues of women with SPE. Notably, miR-1246 was found to be overexpressed in a variety of cancers (27, 35, 47) . Both endogenous and secreted miR-1246 were reported to be upregulated in multiple myeloma, as well as carcinomas of the colon, pancreas, cervix, oral squamous cells, esophagus, and liver (27, 47) . In cancer cells, miR-1246 promotes proliferation, migration, and invasion through targeting thrombospondin 2 and promotes self-renewal and chemoresistance by targeting cyclin G2 (48) . Relevant to our findings, it was observed that the b-catenin destruction complex, consisting of GSK3b and AXIN2, was disrupted upon miR-1246 overexpression, resulting in b-catenin activation (35) . Using luciferase reporter assays, GSK3b and AXIN2 were previously validated as direct targets of miR-1246 (35) .
Studies using gene-targeted mice indicate a crucial role of Wnt/b-catenin signaling pathway components Wnt2, Fzd5, R-spondin2, and Bcl9l in trophoblast branching morphogenesis, labyrinth development, and SynT fusion (19, 23, 36, 37) . Gcm1 upregulates Fzd5 at sites in the basal chorion where branching is initiated. In turn, Fzd5/ b-catenin maintains Gcm1 expression in a positive feedback loop (23) . Thus, b-catenin/Bcl9 promotes SynT fusion by positively regulating the GCM1/syncytin pathway (26) . These findings, together with those from our laboratory, suggest that downregulation of the miR-17;92 cluster (which directly targets aromatase and GCM1 (20) and the miR-515 family (which targets aromatase, GCM1, and WNT receptor Fzd5) (21) and upregulation of miR-1246 promote trophoblast differentiation by cooperatively targeting various positive and negative regulators of WNT signaling and activate GCM1 and aromatase expression, which are critical for SynT differentiation.
In addition to GSK3b and AXIN2, miR-1246 also is predicted to target JARID2, which we found to be significantly downregulated during SynT differentiation. JARID2, a cofactor of PRC2, recruits PRC2 to chromatin surrounding developmentally regulated genes, resulting in trimethylation of histone H3K27 and transcriptional repression (49) . The finding that JARID2 was downregulated during SynT differentiation in 20% O 2 and elevated when the cells were cultured in 2% O 2 suggests that JARID2 may serve an important role in the regulation of genes critical for trophoblast differentiation. Recently, JARID2 was found to increase metastasis of proliferative first trimester HTR8/SVneo trophoblast cells. In that study, knockdown of JARID2 significantly inhibited the viability, migration, and invasion of these cells through downregulation of MMP2, MMP9, and PI3K/AKT signaling (50) . Thus, it was suggested that JARID2 may serve a critical role in trophoblast invasion during 8 to 10 weeks of gestation (50) . Notably, JARID2 was reduced after 12 to 14 weeks of pregnancy (50) when invasion is curtailed and SynT differentiation is increased. However, whether JARID2 is a direct target of miR-1246 remains to be determined. PPARg were significantly elevated during trophoblast differentiation and were markedly reduced upon NRF2 knockdown. Values are the mean 6 SEM; n = 6 from three independent cell preparations. *P , 0.05, **P , 0.01, ***P , 0.001 vs 0 hours;
In the present study, miR-1246 was observed to be upregulated by ;150-fold during SynT differentiation. The magnitude of this induction is quite unusual for miRNAs, which normally are altered by only several fold. This motivated us to identify the molecular mechanisms for this remarkable induction. Using the TF binding algorithm we found that the redox-sensitive transcription factor NRF2 has two potential binding sites in the miR-1246 promoter and three potential binding sites in the hCYP19A1 placenta-specific promoter (Fig. 6) . Using ChIP-qPCR, we observed that binding of endogenous NRF2 to the miR-1246 and placenta-specific hCYP19A1 promoters was significantly increased during SynT differentiation (Fig. 6) . Moreover, NRF2 knockdown blocked temporal induction of aromatase and miR-1246 in cultured trophoblasts (Fig. 5) . Importantly, we observed that NRF2 expression was coordinately increased with aromatase and miR-1246 during SynT differentiation in 20% O 2 ; aromatase, miR-1246 (Fig. 3) , and NRF2 (Fig. 4) were reduced in cells cultured in 2% O 2 and in placentas of women with SPE (Figs. 2 and 4) (18) . Previous studies indicated that placentas of women with PE express decreased levels of NRF2 compared with normotensive subjects (32), whereas Nrf2 knockout mice manifested impaired fetal and placental growth and a reduced labyrinth volume (51) .
Notably, we also observed that NRF2 knockdown inhibited expression of C/EBPb and PPARg, which were upregulated during trophoblast differentiation in culture (Fig. 5) . Previously it was observed that NRF2 upregulated transcription of C/EBPb (52) and PPARg (53) in preadipocytes. A role for C/EBPb in human placental differentiation was suggested by the presence of a functional C/EBPb response element upstream of hCYP19A1 exon I.1 (54) . During adipocyte differentiation, rapid induction of C/EBPb increases expression of PPARg, which regulates hundreds of genes (55) . Notably, Ppargnull mouse embryos die at embryonic day 10 because of pronounced defects in placental labyrinth formation, whereas Pparg-null mouse trophoblast stem cells fail to differentiate into SynT and manifest reduced expression of Gcm1 (56) .
NRF2 is a redox-regulated transcription factor that serves crucial roles in modulation of cellular defense mechanisms against endogenous and exogenous stress. NRF2 mediates antioxidant signaling and cell survival responses, regulates a wide variety of cytoprotective responses, and helps to attenuate metabolic, neurodegenerative, and other age-related diseases (57). NRF2, described as a "primary mediator of cellular adaptation to oxidative stress," is a cap'n'collar basic-leucine zipper transcription factor that heterodimerizes with small MAF proteins and binds to antioxidant response elements in promoters of antioxidant genes (e.g., HMOX1, MnSOD) (58). NRF2 is regulated in response to changes in cellular redox state. At relatively low O 2 tension, NRF2 is repressed because of its interaction in the cytoplasm with KEAP1 (iNRF2), an adaptor protein that facilitates NRF2 ubiquitination and degradation by the 26S proteasome (59) . Apart from oxygen tension, NRF2 phosphorylation by GSK3b reduces NRF2 levels, and mechanistic studies have shown that inhibition of GSK3b resulted in the upregulation of NRF2-dependent antioxidant activity (60) . As shown in the present study, GSK3b, a proven target of miR-1246, is downregulated during SynT differentiation. This may contribute to NRF2 activation. Notably, NRF2 mRNA is a confirmed target of the miR-17 family encoded within the miR-17;92 cluster and paralogs (61), which we found to decline markedly during SynT differentiation (20) . CEBPb, which is induced during trophoblast differentiation and upregulated by NRF2, was shown to bind to the intronic promoter of the miR-17;92 cluster and inhibit its expression, suggesting that regulation of these transcription factors and miRNAs are intertwined and very critical for differentiation (62) . Further studies on the role of the miR-17 family in regulating NRF2 are ongoing.
In summary, in these studies we provide evidence for the important role of miR-1246 in the regulation of trophoblast differentiation and its aberrant expression in PE. Our findings suggest that miR-1246 promotes SynT differentiation by targeting negative regulators of the WNT/b-catenin signaling pathway. Moreover, we discovered that the transcription factor NRF2 serves a multifaceted role in human trophoblast differentiation through induction of aromatase and miR-1246, and via its action to upregulate expression of the key transcription factors C/EBPb and PPARg.
